Asli Altunbas | Medicine and Dentistry | Young Researcher Award

Young Researcher Award

Asli Altunbas
Bahcesehir University School of Medicine, Türkiye

Asli Altunbas
Affiliation Bahcesehir University School of Medicine
Country Türkiye
Scopus ID 59476326700
Documents 3
Citations 1
h-index 1
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Asli Altunbas is a medical researcher and final-year medical student at Bahçeşehir University School of Medicine in Istanbul, Türkiye. Her academic portfolio demonstrates active engagement in clinical medicine, pathology, oncology, pediatrics, cardiovascular sciences, and translational healthcare research. Through scholarly publications, international observership experiences, and student-led educational initiatives, she has contributed to the development of evidence-based medical knowledge and interdisciplinary clinical learning.[1]

Abstract

This academic profile summarizes the educational background, research activities, scientific publications, leadership roles, and community engagement of Sabire Aslı ALTUNBAŞ. Her work spans pediatric health, oncology, pathology, cardiovascular medicine, and medical education. Through active participation in clinical research and international academic collaborations, she has demonstrated a commitment to advancing healthcare knowledge and promoting evidence-based medicine among future healthcare professionals.[2]

Keywords

Medical Research, Oncology, Pathology, Pediatrics, Cardiology, Clinical Education, Artificial Intelligence in Medicine, Translational Research, Medical Students, Healthcare Innovation.

Introduction

Medical students increasingly contribute to scientific discovery through research participation and interdisciplinary collaboration. Sabire Aslı ALTUNBAŞ represents this emerging generation of clinician-scientists through her involvement in peer-reviewed publications, medical education projects, and clinical observation programs. Her academic journey reflects a strong integration of clinical learning, scientific inquiry, and professional development.[1]

Research Profile

Her research interests encompass oncology, neuropathology, pediatric health, inflammatory biomarkers, cardiovascular medicine, and artificial intelligence applications in healthcare. She has participated in retrospective clinical studies, pathology investigations, and comparative analyses involving AI-assisted clinical interpretation. These activities demonstrate an interdisciplinary approach to addressing contemporary healthcare challenges.[3]

Research Contributions

  • Co-authored studies investigating pediatric inflammatory biomarkers and body mass index associations.
  • Contributed to pathology research on primary central nervous system lymphomas.
  • Participated in studies exploring recurrence predictors in granulosa cell tumors.
  • Engaged in research comparing human expertise and artificial intelligence in neonatal intensive care decision support.
  • Supported policy-oriented healthcare initiatives concerning refugee health systems.

Publications

  • Association Between Body Mass Index Categories and Hemogram-Derived Ratios and Inflammatory Indices in Children Aged 6–9 Years. DOI: 10.12659/MSM.952004
  • Primary Central Nervous System Lymphomas and Immune-Privileged Site Lymphomas. DOI: 10.4103/ijpm.ijpm_401_24
  • Predicting Recurrence in Adult Granulosa Cell Tumors: The Role of KI67, p53 and TERT Mutations.
  • Time is Brain: Early Diagnosis of Post-Transplant Lymphoproliferative Disorder Presenting as Primary CNS Diffuse Large B-Cell Lymphoma (Under Review).

Research Impact

Beyond publications, Altunbaş has expanded her academic experience through observerships at Mayo Clinic in heart failure, transplantation medicine, and radiology. She has also established peer-learning initiatives that support practical clinical skills training among pre-clinical medical students. These contributions highlight her commitment to research dissemination, mentorship, and healthcare education.[4]

Award Suitability

Based on her academic achievements, publication record, leadership initiatives, and international clinical exposure, Sabire Aslı ALTUNBAŞ demonstrates characteristics associated with emerging excellence in medical research. Her multidisciplinary engagement and commitment to scientific inquiry make her a suitable candidate for recognition within early-career and student researcher award categories.[2]

Conclusion

Sabire Aslı ALTUNBAŞ has developed a promising academic profile characterized by research productivity, clinical engagement, educational leadership, and community service. Her ongoing contributions to medicine and healthcare research illustrate a strong foundation for future scientific and clinical accomplishments.

References

  1. Bahçeşehir University School of Medicine. Academic and professional profile of Sabire Aslı ALTUNBAŞ.
  2. Altunbaş, S.A. Research activities, leadership initiatives, and academic achievements compiled from curriculum vitae records.
  3. Association Between Body Mass Index Categories and Hemogram-Derived Ratios and Inflammatory Indices in Children Aged 6–9 Years.https://doi.org/10.12659/MSM.952004
  4. Indian Journal of Pathology and Microbiology. Primary Central Nervous System Lymphomas.https://doi.org/10.4103/ijpm.ijpm_401_24

Yang Jilong | Medicine and Dentistry | Innovative Research Award

Innovative Research Award

Yang Jilong
Affiliation Tianjin Medical University Cancer Hospital
Country China
Scopus ID 12788119200
Documents 119
Citations 2701
h-index 28
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Yang Jilong
Tianjin Medical University Cancer Hospital,China

Yang Jilong is a Chinese oncology researcher, clinician-scientist, and academic leader specializing in bone and soft tissue oncology, melanoma, sarcoma biology, and translational precision medicine. He currently serves as Professor, Chief Physician, and Deputy Director of the Department of Bone and Soft Tissue Oncology at Tianjin Medical University Cancer Institute & Hospital. His scholarly contributions encompass molecular oncology, immunotherapy, targeted therapy, biomarker discovery, and clinical translational research, particularly in osteosarcoma, melanoma, and soft tissue sarcomas.[1]

Abstract

Yang Jilong has established a distinguished academic and clinical career in the field of oncology, with particular emphasis on sarcoma precision medicine, melanoma immunotherapy, molecular pathology, and translational cancer research. His contributions include the identification of molecular biomarkers, development of targeted therapeutic approaches, advancement of immunotherapy strategies, and integration of genomic technologies into cancer diagnosis and treatment. Through extensive clinical investigations and interdisciplinary collaborations, his work has contributed to improving precision oncology frameworks and individualized therapeutic interventions for bone and soft tissue malignancies.[2]

Keywords

Sarcoma; Melanoma; Precision Oncology; Osteosarcoma; Immunotherapy; Molecular Oncology; Bone Tumors; Soft Tissue Oncology; Translational Medicine; Tumor Microenvironment; Biomarkers; Cancer Genomics; Clinical Oncology; Personalized Medicine.

Introduction

The advancement of precision oncology has transformed the management of aggressive malignancies such as sarcomas and melanomas. Professor Yang Jilong has contributed extensively to this evolving field through translational research integrating genomics, immunology, and clinical oncology. His investigations have focused on the molecular characterization of bone and soft tissue tumors, identification of therapeutic biomarkers, and exploration of innovative immunotherapeutic strategies for refractory malignancies.[3]

Research Profile

Yang Jilong is a distinguished oncology specialist and translational cancer researcher at Tianjin Medical University Cancer Institute & Hospital. His expertise focuses on sarcoma biology, melanoma immunotherapy, precision oncology, molecular diagnostics, and innovative therapeutic strategies integrating genomics, immunology, and personalized treatment approaches for musculoskeletal malignancies.[5]

Research Contributions

Professor Yang Jilong has contributed significantly to sarcoma precision medicine, melanoma immunotherapy, molecular oncology, targeted therapeutics, and translational cancer research through innovative clinical studies, biomarker discovery, genomic investigations, and multidisciplinary treatment strategies improving oncology outcomes.

Publications

Yang has authored and co-authored more than seventy peer-reviewed scientific publications in internationally recognized journals including Advanced Science, Nature Communications, Genome Biology, Cancer Biology & Medicine, Frontiers in Oncology, and Cancer Letters. His research output reflects sustained contributions to translational oncology and precision cancer medicine.[2]

  • Genome-Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma. Advanced Science, 2026.
  • A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature Communications, 2022.
  • IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters, 2020.
  • Mesenchymal to epithelial transition in sarcomas. European Journal of Cancer, 2014.
  • Genetic amplification of VEGFA pathway genes in osteosarcoma. Cancer, 2011.

Research Impact

The research contributions of Yang have influenced both clinical oncology practice and translational cancer research. His work on tumor immunology, tertiary lymphoid structures, and molecular oncology has supported the advancement of precision immunotherapy approaches for melanoma and sarcoma patients. Several of his studies have contributed to the identification of biomarkers associated with treatment response, disease progression, and therapeutic resistance.[3]

Award Suitability

Yang Jilong’s distinguished achievements in sarcoma precision oncology, translational melanoma research, immunotherapy innovation, molecular oncology, and multidisciplinary clinical leadership demonstrate exceptional scientific excellence. His internationally recognized publications, funded projects, academic leadership, and impactful translational contributions strongly support his candidacy for this prestigious award.

Concluion

Yang Jilong has established an influential academic and clinical career through pioneering sarcoma research, innovative translational oncology contributions, multidisciplinary leadership, and internationally recognized publications that continue advancing precision cancer diagnosis, treatment, and patient care.

References

  1. Tianjin Medical University Cancer Institute & Hospital. (2026). Professional profile of Professor Yang Jilong.
  2. Wang Z, Liu H, Wang X, et al. (2026). Genome-Wide CRISPR Screen Identifies a microRNA Orchestrating Pleiotropic Resistance to Targeted Therapy and T Cell Immunity in Melanoma. Advanced Science.
    https://doi.org/10.1002/advs.202515158
  3. Zhang C, Shen H, Yang T, et al. (2022). A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. Nature Communications.
    https://www.nature.com/articles/s41467-022-34937-1
  4. Li T, Zhang C, Zhao G, et al. (2020). IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma. Cancer Letters.
    https://doi.org/10.1016/j.canlet.2020.01.015
  5. Yang J, Yang D, Sun Y, et al. (2011). Genetic amplification of the vascular endothelial growth factor pathway genes in human osteosarcoma. Cancer.
    https://doi.org/10.1002/cncr.26121

Ji Young Yoon | Medicine and Dentistry | Research Excellence Award

Research Excellence Award

Ji Young Yoon
Assistant Professor, Department of Orthopaedic Surgery, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea

Ji Young Yoon
Affiliation Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea
Country South Korea
Scopus ID 59046754400
Documents 1
Citations 6
h-index 1
Subject Area Medicine and Dentistry
Event International Academic Achievements & Awards

Dr. Ji Young Yoon is an orthopaedic surgeon and academic researcher specializing in shoulder surgery, arthroscopy, sports medicine, and rotator cuff pathology. As an Assistant Professor at Eulji University School of Medicine, Dr. Yoon has contributed extensively to clinical orthopaedic research through multicenter studies, randomized clinical trials, and translational surgical investigations focused on improving patient outcomes and rehabilitation strategies.[1]

Abstract

Dr. Ji Young Yoon has established a distinguished academic and clinical profile in orthopaedic surgery with research emphasizing arthroscopic shoulder procedures, rotator cuff repair, reverse shoulder arthroplasty, and postoperative rehabilitation. Through collaborative clinical investigations and evidence-based surgical studies, Dr. Yoon has contributed to advancing modern orthopaedic treatment methodologies, surgical optimization, and patient-centered musculoskeletal care.[2]

Keywords

Orthopaedic Surgery, Arthroscopy, Rotator Cuff Repair, Reverse Shoulder Arthroplasty, Sports Medicine, Shoulder Surgery, Rehabilitation, Musculoskeletal Research, Arthroscopic Surgery, Clinical Orthopaedics

Introduction

The field of orthopaedic surgery continues to evolve through advancements in minimally invasive procedures, biologic augmentation, and rehabilitation sciences. Dr. Ji Young Yoon has actively participated in these developments through clinical research and academic leadership in shoulder and sports medicine. His work integrates surgical precision with evidence-based postoperative management strategies to improve functional recovery and long-term patient outcomes.[3]

Research Profile

Dr. Yoon serves as Assistant Professor at Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, South Korea. He is an active member of the Korean Orthopaedic Association, Korean Shoulder and Elbow Society, Korean Arthroscopy Society, and APKASS. Additionally, he contributes to the academic community as a reviewer for several international journals including the Journal of Shoulder and Elbow Surgery, Clinics in Orthopedic Surgery, and AP-SMART.[4]

  • Specialization in shoulder and elbow surgery
  • Clinical expertise in arthroscopic reconstruction techniques
  • Research focus on rotator cuff healing and rehabilitation
  • Reviewer for international orthopaedic journals
  • Member of the 2026 APKASS Organizing Committee

Research Contributions

Dr. Yoon’s research contributions encompass prospective randomized trials, multicenter studies, imaging-based diagnostics, biologic therapies, and arthroscopic innovations. His investigations into rotator cuff repair, postoperative pain management, dermal fibroblast injection therapy, and reverse shoulder arthroplasty have contributed to contemporary orthopaedic surgical practices.[5]

  • Development of clinical protocols for arthroscopic shoulder surgery
  • Research on tendon-to-bone healing enhancement strategies
  • Evaluation of MRI predictors in shoulder stiffness and rotator cuff tears
  • Studies on biologic augmentation and dermal allograft applications
  • Clinical evaluation of reverse total shoulder arthroplasty outcomes

Publications

Dr. Ji Young Yoon has authored and co-authored numerous peer-reviewed publications in orthopaedic surgery and sports medicine. His scholarly work focuses on shoulder arthroscopy, rotator cuff repair, reverse shoulder arthroplasty, rehabilitation protocols, biologic augmentation, and postoperative outcomes, contributing significantly to evidence-based musculoskeletal surgery and clinical orthopaedic advancement worldwide.[5]

Research Impact

The clinical significance of Dr. Yoon’s work is reflected in his contributions to surgical optimization, patient rehabilitation, and translational orthopaedic research. His investigations have supported improved understanding of tendon healing, arthroscopic outcomes, biologic interventions, and shoulder biomechanics, thereby strengthening evidence-based surgical practice in orthopaedics.

Award Suitability

Dr. Ji Young Yoon demonstrates strong suitability for international academic recognition due to his sustained contributions to orthopaedic surgery research, clinical innovation, scientific publishing, and professional leadership. His receipt of multiple Korean Orthopaedic Association Best Poster Awards and national commendation certificates further reflects academic excellence, clinical dedication, and impactful research engagement.

Conclusion

Dr. Ji Young Yoon has established a respected academic and clinical presence within the field of orthopaedic surgery through his multidisciplinary research, evidence-based surgical investigations, and scholarly collaborations. His work continues to support advancements in shoulder surgery, sports medicine, and musculoskeletal rehabilitation while contributing to the broader international orthopaedic research community.

References

  1. American Journal of Sports Medicine. (2012). Clinical comparison of conventional and remnant-preserving transtibial single-bundle posterior cruciate ligament reconstruction.https://journals.sagepub.com/home/ajs
  2. Journal of Shoulder and Elbow Surgery. (2020). Effect of tranexamic acid on blood loss after reverse total shoulder arthroplasty.https://doi.org/10.1016/j.jse.2020.01.091
  3. The Korean Journal of Pain. (2020). Far-infrared radiation and tendon-to-bone healing after arthroscopic rotator cuff repair.https://www.epain.org/
  4. Journal of Shoulder and Elbow Surgery International. (2023). Predictive MRI findings of rotator cuff tear concomitant with shoulder stiffness.https://www.jsesinternational.org/
  5. Orthopaedic Journal of Sports Medicine. (2021). Safety and efficacy of autologous dermal fibroblast injection after rotator cuff repair.https://journals.sagepub.com/home/ojs